
Casid Pharmaceuticals Private Limited
Manufactures and distributes medical products and supplies, including pharmaceuticals, surgical goods, and diagnostic kits.
Manufactures and distributes medical products and supplies, including pharmaceuticals, surgical goods, and diagnostic kits.
Casid Pharmaceuticals Private Limited (CPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 July 2019 (Five years and seven months 17 days old ). Its registered office is in Tiruchirappalli, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nirmal Kathiravan and Jeyaraman Senthilkumar serve as directors at the Company.
Tiruchirappalli, Tamil Nadu, India
+91-XXXXXXXXXX
-
U24100TN2019PTC130614
130614
Private Limited Indian Non-Government Company
19 Jul 2019
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nirmal Kathiravan ![]() | Director | 02-May-2024 | Current |
Jeyaraman Senthilkumar ![]() | Director | 19-Jul-2019 | Current |
Enhance accessibility to Casid Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Casid Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Nirmal Kathiravan is a mutual person
Jeyaraman Senthilkumar is a mutual person
Nirmal Kathiravan and Jeyaraman Senthilkumar are mutual person
Nirmal Kathiravan and Jeyaraman Senthilkumar are mutual person
Nirmal Kathiravan is a mutual person
Nirmal Kathiravan is a mutual person
There are no open charges registered against the company as per our records.
Casid Pharmaceuticals has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Casid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Casid Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nirmal Kathiravan was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 10 months 2 days .
Casid Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Casid Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
Jeyaraman Senthilkumar was appointed as a Director was appointed as a Director on 19 Jul 2019 & has been associated with this company since 5 years 7 months .
Casid Pharmaceuticals Private Limited was registered on 19 Jul 2019 with Roc Chennai & aged 5 years 7 months as per MCA records.
Casid Pharmaceuticals Private Limited was incorporated on 19 Jul 2019.
The authorized share capital of Casid Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 2 directors are associated with Casid Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Casid Pharmaceuticals Private Limited is S.F. No. 115/15 Trichy To Chennai Trunk Road Samayyapuram Village And Panchayat, Manachanalur Taluk India, Manachanalloor, Tamil Nadu, 621112.
The corporate identification number (CIN) of Casid Pharmaceuticals Private Limited is U24100TN2019PTC130614 and the company number is 130614 as per Ministry of Corporate Affairs (MCA).
As Per 0 financial reports, 7 employees are currently employed by Casid Pharmaceuticals Private Limited.
The most recent Balance Sheet for Casid Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
K
SM
GR